Serodiagnosis of flaviviral infections and vaccinations in humans (Q35625007)

9 August 2017

1 reference

title

Serodiagnosis of flaviviral infections and vaccinations in humans (English)

1 reference

9 August 2017

Goro Kuno

1

1 reference

PubMed ID

14714429

9 August 2017

language of work or name

1 reference

1 January 2003

1 reference

9 August 2017

63

1 reference

Advances in Virus Research

inferred from page(s)

published in

1 reference

9 August 2017

61

1 reference

9 August 2017

3-65

1 reference

Possible clinical infection with Edge Hill virus

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Pharmacokinetics of human tick-borne encephalitis virus antibody levels after injection with human tick-borne encephalitis immunoglobulin, solvent/detergent treated, FSME-BULIN S/D in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Evaluation of vero cell lysate antigen for the ELISA of flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Diagnosis of dengue infection by detecting specific immunoglobulin M antibodies in saliva samples

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Preliminary studies on the use of solid-phase immunosorbent techniques for the rapid detection of Wesselsbron virus (WSLV) IgM by haemagglutination-inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Comparison of an antibody-capture IgM enzyme-linked immunosorbent assay with IgM-indirect immunofluorescence for the diagnosis of acute Sindbis and West Nile infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Study of bivalent dengue vaccine in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Indirect Fluorescent Antibody Technic for Demonstration of Serum Antibody in Dengue Hemorrhagic Fever Cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Prenatal transmission of dengue: two new cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

An enzyme-linked immunosorbent assay for detection of flavivirus antibodies in chicken sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Detection of flavivirus antibodies in human serum by epitope-blocking immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A nitrocellulose membrane based IgM capture enzyme immunoassay for etiological diagnosis of dengue virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

TWO EPISODES OF DENGUE FEVER, CAUSED BY TYPES 4 AND 1 VIRUSES, IN AN INDIVIDUAL PREVIOUSLY IMMUNIZED AGAINST YELLOW FEVER.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Prevalence of antibody against West Nile virus in volunteer blood donors living in southeastern France

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Transplacental Infection with Japanese Encephalitis Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A shortened dengue IgM capture ELISA using simultaneous incubation of antigen and peroxidase-labeled monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue 1 epidemic in French Polynesia, 1988-1989: surveillance and clinical, epidemiological, virological and serological findings in 1752 documented clinical cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and haemagglutination inhibition (HI) test for the detection of dengue antibodies. Prevalence of dengue IgG-ELISA antibodies in Tahiti

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Storage stability of different antibody species against arbovirus and rickettsial antigens in blood dried on filter paper discs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Detection of immune complexes in the CSF of Japanese encephalitis patients: correlation of findings with outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Murray Valley encephalitis in Australia, 1974: antibody response in cases and community

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A plaque neutralization method for arboviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Human immunoglobulin M antibody in the sero-diagnosis of Japanese encephalitis virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunoglobulin M in the cerebrospinal fluid of patients with arbovirus encephalitis and other infections of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

New virus fingered in Malaysian epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Determination of human IgG and IgM class antibodies to West Nile virus by enzyme linked immunosorbent assay (ELISA).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

An enzyme immunoassay for dengue antibody using infected cultured mosquito cells as antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Testing for West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Flavivirus Type-Specific Antigens Produced from Fusions of a Portion of the E Protein Gene with the Escherichia coli trpe Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Identification of Distinct Antigenic Determinants on Dengue-2 Virus Using Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Early diagnosis of tick-borne encephalitis (TBE) by demonstration of specific IgM antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Technology transitions: time to terminate the term 'titre'?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Diagnostic value of dengue virus-specific IgA and IgM serum antibody detection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A case of natural concurrent human infection with two dengue viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Hemadsorption immunosorbent technique for the detection of dengue immunoglobulin M antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Etiologies of the Experimental Dengues of Siler and Simmons *

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Serological response to Japanese B encephalitis vaccine of children and horses immune to St. Louis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Defined epitope blocking with Murray Valley encephalitis virus and monoclonal antibodies: laboratory and field studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Serotyping of Dengue Viruses by an Immune Adherence Hemagglutination Test

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Production of human monoclonal and polyclonal antibodies in TransChromo animals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Influence of rheumatoid factor on the specificity of a rapid immunochromatographic test for diagnosing dengue infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

The development and application of the latex agglutination test to detect serum antibodies against Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

The micro-focus reduction neutralization test for determining dengue and Japanese encephalitis neutralizing antibodies in volunteers vaccinated against dengue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunoglobulin M-capture biotin-streptavidin enzyme-linked immunosorbent assay for detection of antibodies to dengue viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Evaluation of an IgM immunoblot kit for dengue diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

An ELISA procedure for the diagnosis of dengue infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Antigen capture ELISA for the identification of dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Study of anti-dengue NS1 antibody by western blot

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

[Studies on the titers of hemagglutination inhibition antibody against Japanese encephalitis virus and the result of vaccination in the aged]

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Demonstration of concurrent dengue 1 and dengue 3 infection in six patients by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

An improved method for determining neutralizing antibody against lymphocytic choriomeningitis virus in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Prospective assessment of the etiology of acute febrile illness after a tick bite in Slovenia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue encephalitis: a true entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Studies on serological cross-reaction in sequential flavivirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Rapid and sensitive streptavidin-biotin amplified fluorogenic enzyme-linked immunosorbent-assay for direct detection and identification of dengue viral antigens in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Diagnostic immunoassays for tick-borne encephalitis virus based on recombinant baculovirus protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Epidemiological features of and public health response to a St. Louis encephalitis epidemic in Florida, 1990-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Indirect fluorescent antibody test for the diagnosis of yellow fever

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Comparison of dengue virus plaque reduction neutralization by macro and "semi-micro' methods in LLC-MK2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Concurrent Isolation from Patient of Two Arboviruses, Chikungunya and Dengue Type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Yellow fever vaccination and pregnancy: a four-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Human disease caused by an arbovirus closely related to Ilheus virus: report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

St. Louis encephalitis in patients with human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Fatal encephalitis caused by concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system. Brief report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Coinfections in dengue patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue virus infection during infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunoglobulin E in dengue haemorrhagic fever (DHF) cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dual virus infections. Simultaneous enteroviral disease and St. Louis encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Biphasic illness pattern due to early relapse in Japanese-B virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Persistence of Japanese encephalitis virus in the human nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Development of an Enzyme-linked Immunosorbent Assay for the Identification of Arthropod-borne Togavirus Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Serological diagnosis of acute tick-borne encephalitis by demonstration of antibodies of the IgM class

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Retrospective study of Western blot profiles in immune sera of natural dengue virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralizatio

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Assay of arbovirus neutralizing antibody by micro methods

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Antibody responses in Japanese volunteers after immunization with yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

The serological reactions in yellow fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Development of a simple indirect enzyme-linked immunosorbent assay for the detection of immunoglobulin M antibody in serum from patients following an outbreak of chikungunya virus infection in Yangon, Myanmar

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Development of a simplified assay for the detection of neutralizing antibodies to Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Standardization of a plaque assay for Lassa virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Human Dengue antibodies against structural and nonstructural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue in the early febrile phase: viremia and antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

[Detection of IgM against the dengue++ virus in whole blood absorbed on filter paper]

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A rapid fluorescent focus inhibition test for detection of neutralizing antibodies to tick-borne encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

St Louis encephalitis: a review of 11 cases in a 1995 Dallas, Tex, epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Laboratory infections with loupingill with associated encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

The neutralization of arboviruses. II. Neutralization in heterologous virus-serum mixtures with four group B arboviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunoglobulin M in murray valley encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunological studies with group B arthropod-borne viruses. I. Broadened neutralizing antibody spectrum induced by strain 17D yellow fever vaccine in human subjects previously infected with Japanese encephalitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Long-term stability of West Nile virus IgM and IgG antibodies in diluted sera stored at 4 degrees C.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Development of a particle agglutination assay system for detecting Japanese encephalitis virus-specific human IgM, using hydroxyapatite-coated nylon beads

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Hydroxyapatite-coated nylon beads as a new reagent to develop a particle agglutination assay system for detecting Japanese encephalitis virus-specific human antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Enzyme-linked immunosorbent assay using recombinant antigens expressed in mammalian cells for serodiagnosis of tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Detection of specific antibodies in saliva during dengue infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Original antigenic sin in dengue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Serum and cerebrospinal fluid immunoglobulins M, A, and G in Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Potential use of a Baculovirus-Expressed Dengue-4 E Protein as a Diagnostic Antigen in Regions Endemic for Dengue and Japanese Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Microneutralization test for rabies virus based on an enzyme immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Immunoglobulin E in patients with Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Determination of parallelism and nonparallelism in bioassay dilution curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

A rapid fluorescent focus-inhibition test for determining dengue neutralizing antibody and for identifying prototype dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Reactions of purified hemagglutinating antigens of flaviviruses with 19S and 7S antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Experimental infections of pigs with Japanese encephalitis virus and closely related Australian flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961001-8

7 January 2021

10.1016/S0065-3527(03)61001-8

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14714429